Regen BioPharma Inc (RGBP)

[cvinvestor]

Amazing to me that news rarely seems to create any momentum or upswing as of late. Very discouraging. As previously pointed out, the Pan Am Cancer Treatment Center is both local to San Diego (in sense of a 40 min drive; 26 min from RGBP La Mesa office) and it has on its board current or former Scientific Board members.

In other words, they are working with the people who have been advising them and using, rather agreeing to them carrying on human trials in a non exclusive manner. It may be that the Pan Am human trial data would not be accepted by USA FDA (I'll let the experts comment on that), but since it is a NON-exclusive agreement, it doesn't prevent RGBP from setting up a US based clinical trial in the Q3. Right now they don't have money, but if the Mexican trial begins shortly (or has begun) and RGBP gets positive results at the one month period follow up, then that data alone will be a carrot to attract US BP to finance a US based trial and Pan Am can go forward in Mexico. So I don't see from the PR why this news causes the stock to drop to 52 week lows.

If it were an exclusive agreement, I would read it as a US failure, 2nd choice option, but since HemaX trials were not to begin until Q3 and these are people associated with the Company, why would it be seen as negative?